Edward Tate

  • Home
  • Author: Edward Tate
Edward Tate January 15, 2026 0 Comments

The Baruch S. Blumberg Institute presented the 2025 Lam Excellence in Medicinal and Chemistry Award recently to Dan Nguyen, BS, senior research scientist in medicinal chemistry, Blumberg Institute and Mark E. McDonell, PhD, director of chemistry, Fox Chase

Edward Tate January 9, 2026 0 Comments

Blumberg Institute faculty presented at the HEP-DART 2025, Dec. 7-11, 2025 in Honolulu, Hawaii. HEP-Dart, an in-person meeting, is designed for vibrant scientific presentations and discussion, as well as for new investigators to meet leaders.Yanming Du, professor

Edward Tate January 5, 2026 0 Comments

The Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC) today welcomed NIH Director Jay Bhattacharya, MD, PhD, for a visit highlighting collaborative research, innovation and academic programs advancing public health and biomedical discovery.U.S.

Edward Tate November 20, 2025 0 Comments

Blumberg Institute Distinguished Professor Richard G. Pestell, MD, PhD FACP, FRACP, MBA, gave presentations recently at two international scientific conferences on a promising potential therapy for metastatic triple-negative breast cancer.The new findings presented at European Society for

Edward Tate October 27, 2025 0 Comments

Jinhong Chang, MD, PhD, was chosen for her outstanding research in molecular virology and antiviral drug discovery. The Baruch S. Blumberg Institute presented the Harvey J. Alter Chair, a newly created honor, to Jinhong Chang, MD, PhD,

Edward Tate October 22, 2025 0 Comments

Ju-Tao Guo, MD,  globally recognized expert in hepatitis B virology, will lead the Pennsylvania nonprofit research organization.Ju-Tao Guo, MD, a leading expert in hepatitis B virology, was named president of the Baruch S. Blumberg Institute by its

Edward Tate August 20, 2025 0 Comments

The letter below was sent to U.S. Congressman Guy Reschenthaler and Congresswoman Madeleine Dean on behalf of the Pennsylvania Ad Hoc NIH Funding Advocacy Coalition. A PDF version can be found here.  To : Congressman Guy Reschenthaler 2209

Edward Tate August 18, 2025 0 Comments

Dr. Sofia was responsible for the discovery and early development of sofosbuvir, which became the backbone of many hepatitis C curative therapies.Award-winning scientist Michael J. Sofia, PhD, who discovered the first reliably effective treatment for hepatitis C,

The Hepatitis B Foundation, Baruch S. Blumberg Institute and American Philosophical Society, joined together to celebrate the legacy—and the 100th birthday—of the late Baruch S. Blumberg, MD, DPhil, a Nobel Laureate, on July 29 in Philadelphia.More than

The Hepatitis B Foundation and Baruch S. Blumberg Institute recently presented Nicole E. Geracimos, MD, a Doylestown resident, with the organizations’ first Education Impact Award.Dr. Geracimos was honored at a June 26 event to raise funds for the